These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Lack of cross-resistance to 4-aminoquinolines in chloroquine-resistant Plasmodium falciparum in vitro.
    Author: Geary TG, Jensen JB.
    Journal: J Parasitol; 1983 Feb; 69(1):97-105. PubMed ID: 6338201.
    Abstract:
    The potencies of 10 quinoline-containing antimalarials, including chloroquine, amodiaquine, CM-2,999-2K, quinine, mefloquine, SN-6911, SN-11875, SN-12108, SN-12308, and SN-12309, were determined in vitro against five strains of Plasmodium falciparum characterized in vivo and in vitro by various degrees of sensitivity to chloroquine. These strains included the chloroquine-sensitive strains Honduras and FCC1, and R1-resistant line FCR3TC, and the R3-resistant strains FCR1 and Viet Nam Smith (VNS). The potency of chloroquine varied 100-fold in these strains, with minimum inhibitory concentrations (MIC) ranging from 3.2 X 10(-9) M in FCC1 to 3.2 X 10(-7) M in FCR1. The other drugs had different patterns; SN-12108 had an MIC of 3.2 X 10(-9) M in FCC1, Honduras, and FCR1, and 3.2 X 10(-8) M in VNS. However, SN-6911 (3-methylchloroquine), amodiaquine, and mefloquine showed little or no variation in potency among these strains. There was no correlation between sensitivity to chloroquine and any other drug. This lack of cross-resistance in vitro must be taken into account in consideration of theories of chloroquine action in these parasites.
    [Abstract] [Full Text] [Related] [New Search]